Medtronic Gains Peripheral Pipeline, Drug-Eluting Balloons With Invatec Buy
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's acquisition of Invatec will bolster the cardiac device giant's peripheral vascular offerings and add what could be the next big thing in interventional devices - drug-eluting balloons
You may also be interested in...
Medtronic’s Hawkins To Retire; Company Sets External Search For New CEO
Medtronic Chairman and CEO William Hawkins is retiring after just three years in the firm’s top spot, a move that may reflect the company’s desire to accelerate change and diversification in the face of sluggish growth in signature businesses.
Medtronic’s Hawkins To Retire; Company Sets External Search For New CEO
Medtronic Chairman and CEO William Hawkins is retiring after just three years in the firm’s top spot, a move that may reflect the company’s desire to accelerate change and diversification in the face of sluggish growth in signature businesses.
Covidien Makes Big Play In Endovascular With $2.6 Billion ev3 Deal
Covidien says its large international operations will further accelerate ev3's fast-growing neurovascular and peripheral vascular businesses following its planned $2.6 billion acquisition of the endovascular firm